News Conference News AHA 2017 More Support for TMVR After Failed Mitral Bioprostheses Yael L. Maxwell November 23, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Conference News TCT 2017 One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block Michael O'Riordan October 31, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
News Conference News ESC 2017 Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days Michael O'Riordan August 31, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Conference News EuroPCR 2017 Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2017 The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone Yael L. Maxwell May 17, 2017
News Conference News ACC 2017 TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes Shelley Wood March 24, 2017
News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016
News Conference News PCR London Valves 2016 Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon Shelley Wood September 20, 2016
News Conference News ESC 2016 Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy Todd Neale September 02, 2016
News Conference News EuroPCR 2016 Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices Michael O'Riordan May 23, 2016
News Conference News EuroPCR 2016 ‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices Caitlin E. Cox May 17, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial Yael L. Maxwell April 03, 2016
News Conference News ACC 2016 TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral Shelley Wood April 02, 2016